Literature DB >> 2524023

Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.

T Subramanian1, M La Regina, G Chinnadurai.   

Abstract

Mutants of adenovirus 2 E1a defective in coding for the C-terminal 61 or 67 amino acids of a 243 amino acid (243R) protein are defective in immortalization of primary baby rat kidney (BRK) cells. However, they cooperate with T24 ras in oncogenic transformation more efficiently than wt. BRK cells transformed by the E1a C-terminal mutants and T24 ras induce rapidly growing tumors in syngeneic rats and athymic mice whereas cells transformed by the wt 243R and ras oncogene are not tumorigenic in syngeneic rats and can only induce slowly growing tumors in athymic mice. Cells transformed by the E1a mutants and ras oncogene also induce rapid metastatic tumors whereas cells transformed by the wt 243R and T24 ras can not do so. The increased tumorigenic ability exhibited by the 243R mutants does not appear to be due to differential levels of expression of p21 ras. Our results suggest that the C-terminal region of the 243R protein may have a novel function in suppression of cell transformation, tumorigenesis and tumor progression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524023

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C.

Authors:  R Touitou; M Hickabottom; G Parker; T Crook; M J Allday
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

3.  Inhibition of transcriptional activation and cell proliferation activities of adenovirus E1A by the unique N-terminal domain of CtBP2.

Authors:  L-J Zhao; T Subramanian; G Chinnadurai
Journal:  Oncogene       Date:  2008-05-19       Impact factor: 9.867

Review 4.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

5.  The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation.

Authors:  K Sollerbrant; G Chinnadurai; C Svensson
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

6.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.

Authors:  U Schaeper; J M Boyd; S Verma; E Uhlmann; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

9.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Interaction of ZEB and histone deacetylase with the PLDLS-binding cleft region of monomeric C-terminal binding protein 2.

Authors:  Ling-Jun Zhao; M Kuppuswamy; S Vijayalingam; G Chinnadurai
Journal:  BMC Mol Biol       Date:  2009-09-15       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.